KoBioLabs, Inc (348150.KQ)
- Previous Close
4,980.00 - Open
0.00 - Bid --
- Ask --
- Day's Range
0.00 - 0.00 - 52 Week Range
0.00 - 8,920.00 - Volume
0 - Avg. Volume
188,464 - Market Cap (intraday)
96.482B - Beta (5Y Monthly) 0.70
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
KoBioLabs, Inc. provides microbiome therapeutics for metabolic, immune, and neurological diseases. The company is based in Seongnam-si, South Korea.
kobiolabs.comRecent News: 348150.KQ
View MorePerformance Overview: 348150.KQ
Trailing total returns as of 5/15/2025, which may include dividends or other distributions. Benchmark is KOSPI Composite Index (^KS11) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 348150.KQ
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 348150.KQ
View MoreValuation Measures
Market Cap
94.16B
Enterprise Value
54.96B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.40
Price/Book (mrq)
2.55
Enterprise Value/Revenue
0.84
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-7.75%
Return on Assets (ttm)
-3.98%
Return on Equity (ttm)
-7.87%
Revenue (ttm)
68.36B
Net Income Avi to Common (ttm)
-5.3B
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
55.83B
Total Debt/Equity (mrq)
29.81%
Levered Free Cash Flow (ttm)
-11.46B